FindTrial
Sign In

Prospective randomised controlled study of transurethral enucleation of the prostate with predisconnection of prostatic apex versus standard transurethral enucleation of the prostate

Prospective randomised controlled study of transurethral enucleation of the prostate with predisconnection of prostatic apex versus standard transurethral enucleation of the prostate

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082651
Enrollment
Unknown
Registered
2024-04-02
Start date
2024-04-15
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign prostatic hyperpIasia

Interventions

test group:transurethral enucleation of the prostate with predisconnection of prostatic apex
control group:standard transurethral enucleation of the prostate

Sponsors

First Affiliated Hospital of Gannan Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1: Age 60-80;2:Maximum urine flow rate = 10 m L / s;3:Transrectal prostate ultrasound of the prostate 50-80g

Exclusion criteria

Exclusion criteria: 1:Combined progressive malignant tumours;2:Total prostate-specific antigen (PSA) > 20 ng/m L or free PSA/total PSA < 0.16;3:Combined with urethral stricture;4:Combined central or peripheral neuropathy;5:Patients with contraindications to surgery, e.g., severe cardiopulmonary disease, coagulation disorders

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative incontinence;—

Secondary

MeasureTime frame
Postoperative urodynamic testing;—

Countries

China

Contacts

Public ContactZhang Guoxi

First Affiliated Hospital of Gannan Medical University

zgx8778@163.com+86 152 7971 9227

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026